Uranium Enrichment Iran: Nuclear Capability and Weaponisation Explained

Context: Uranium Enrichment Iran

After strikes on Natanz and Isfahan, the concern is whether Iran can move from enrichment to a usable and deliverable nuclear weapon

Key Points

1. Enrichment Levels → Natural uranium has U-235 (~0.7%) usable isotope (rest mostly U-238) → enrichment increases U-235 → 3–5% (power) → 20% → 60% → 90% (bomb) → 0–60% hard, 60–90% fast
2. Iran’s Material Position → ~500 kg at 60% → can reach 90% in ~2 weeks → ~25 kg enough for 1 bomb → material stage nearly achieved
3. Weaponisation Gap → gas to metal conversion → core shaping → detonation system → needs precision; takes weeks to months
4. Delivery Systems → Shahab-3 (~1000–1300 km, ~700–1000 kg payload), Sejjil (~2000 km, solid fuel) → range and payload adequate; integration uncertain
5. Core Issue → miniaturisation of warhead + survival during re-entry + integration with missile → most complex and decisive barrier

INS Aridaman Nuclear Submarine: India’s Second Strike Capability Explained

Context: INS Aridaman Nuclear Submarine

India inducted INS Aridaman (~7000 tonnes), strengthening the sea-based leg of nuclear deterrence and assured second-strike capability.

Key Points

1. Platform Role
   • Nuclear-powered submarine carrying ballistic missiles with nuclear warheads
   • Can remain underwater for months → difficult to detect
   • Ensures retaliation even after first strike
   
2. Capability Expansion (India)
   • INS Arihant (2016) → 4 launch tubes
   • INS Arighaat (2024) → improved systems
   • INS Aridaman (2026) → ~7000 tonnes, 8 launch tubes
   • Result → higher missile load + longer endurance + better survivability
   
3. Missile Capability
   • K-15 Sagarika → ~700–750 km
   • K-4 → ~3500 km
   • Both are submarine-launched ballistic missiles carrying nuclear warheads
   
4. Range Advantage
   • K-15 required submarines to move closer to enemy coast
   • K-4 enables strikes from deep sea zones
   • Result → lower detection risk + safer deployment
   

Strategic Impact
• Sea-based platform = most survivable leg of nuclear triad
• More missiles per patrol + longer underwater stay
• Ensures credible second-strike capability

UN Peacekeeping South Sudan: India’s Role in UNMISS Explained

Context: UN Peacekeeping South Sudan

UN appreciated Indian peacekeepers in South Sudan for reopening the Malakal–Renk corridor, restoring humanitarian access in flood- and conflict-affected areas under the United Nations Mission in South Sudan.

Key Points

1. Legal Basis and Nature
   Based on Article 24 of the Charter of the United Nations → UN Security Council maintains international peace and security → missions created through UNSC mandates → operate on consent, impartiality and limited use of force
   
2. What UN Peacekeeping Does
   Maintains peace, protects civilians, supports political processes, enables humanitarian aid, rebuilds basic infrastructure → now multidimensional (security + governance + relief)
   
3. Major Missions
   Africa: UNMISS | MONUSCO | MINUSMA | UNISFA | MINURSO
   Middle East: UNIFIL | UNDOF | UNTSO
   Europe: UNFICYP | UNMIK
   Asia: UNMOGIP
   

India’s Role in South Sudan (UNMISS)
• India among largest troop contributors (~1700+ personnel)
• Indian engineers reopened Malakal-Renk supply route
• Enabled humanitarian aid delivery and connectivity restoration
• Contribution includes infrastructure repair, medical support and civilian protection
• Reflects India’s role as a key stabilising and humanitarian actor

US Tariff Patented Pharma: Impact on India’s Pharmaceutical Exports

Context: US Tariff Patented Pharma

The US has imposed a 100% tariff on patented pharmaceutical imports (from July 31) to promote domestic manufacturing and reduce supply dependence; generic drugs are exempt for now, with a review after 12 months.

Key Points

1. What is being taxed (Basics included)
   • Patented drugs → new, innovation-based medicines under patent protection (~20 years), high-cost, no competition
   • Generics → copies made after patent expiry, low-cost, mass supply
   • Tariff applies to patented drugs and related inputs, generics excluded currently
   
2. Why US is doing this
   • Reduce import dependence in a critical sector
   • Boost domestic pharma manufacturing
   • Secure supply chains
   • Strategic push similar to semiconductors/critical tech
   
3. India–US Pharma Link (Data)
   • US = largest market (~40% of India’s pharma exports)
   • India exports ~$9.7 billion (2025)
   • ~90% exports are generics → shielded for now
   
4. Impact on India
   • Short term → limited impact (generics exempt)
   • Direct impact → firms in patented/specialty segment face pressure
   • Risk → if tariffs extend to generics → major export shock
   

Structural Implications
• Push for US-based manufacturing
• Possible decline in reliance on Indian APIs/intermediates
• Opportunity for India to move into high-value pharma (PLI ~₹15,000 crore)

IBC Amendment 2026: Key Changes to Speed Up Insolvency Resolution

Context: IBC Amendment 2026

Parliament passed the IBC (Amendment) Bill, 2026 to address delays, low recovery and litigation-heavy processes, aiming to make insolvency resolution time-bound and more efficient.

Key Changes

1. What the system is + where the problem was
   • IBC (2016) → framework for resolving stressed companies through NCLT (adjudication) and NCLAT (appeals)
   • Intended to be time-bound, but faced delays in admission, long appeals, backlog and low recovery
   
2. How the amendments speed up resolution
   • NCLT must admit cases once default is established → removes entry-stage delays
   • NCLAT given 3-month limit → reduces prolonged appeals
   • Introduction of creditor-led, out-of-court initiation with 51% approval → reduces court burden
   
3. Making the system more practical and flexible
   • Group insolvency → handles interconnected companies together
   • Cross-border insolvency rules → deals with foreign assets and creditors
   • IBBI empowered to fix timelines and standards → better regulation
   

Fixing distortions and improving outcomes
• Resolution Professional cannot act as liquidator → avoids bias toward liquidation
• Shift from criminal to civil penalties → ensures proportional enforcement
• Broader definition of corporate debtor → wider applicability